Log in

688621 Beijing Sun-Novo Pharmaceutical Research Co. Ltd. SSE · China

Beijing Sun-Novo Pharmaceutical Research Co. (688621) news

Beijing Sun-Novo Pharmaceutical Research Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688621, recorded under China. The directory classifies it as Mixed biopharma / other operations. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Beijing Sun-Novo Pharmaceutical Research Co. news

We have not published a story on Beijing Sun-Novo Pharmaceutical Research Co. yet. When there is news, it will appear here.

Questions about Beijing Sun-Novo Pharmaceutical Research Co.

What is the ticker symbol of Beijing Sun-Novo Pharmaceutical Research Co.?

Beijing Sun-Novo Pharmaceutical Research Co. Ltd. trades under the ticker 688621 on SSE.

Where is Beijing Sun-Novo Pharmaceutical Research Co. listed?

Beijing Sun-Novo Pharmaceutical Research Co. Ltd. is listed on SSE.

Which country or territory is Beijing Sun-Novo Pharmaceutical Research Co. listed under?

Our directory records Beijing Sun-Novo Pharmaceutical Research Co. Ltd. under China.

What does Beijing Sun-Novo Pharmaceutical Research Co. do?

Our directory classifies Beijing Sun-Novo Pharmaceutical Research Co. Ltd. as: Mixed biopharma / other operations. This is a directory classification, not a description of the pipeline.

What is the ISIN of Beijing Sun-Novo Pharmaceutical Research Co.?

The ISIN recorded for Beijing Sun-Novo Pharmaceutical Research Co. Ltd. is CNE100005139.

Does aibio.space cover Beijing Sun-Novo Pharmaceutical Research Co.?

aibio.space lists Beijing Sun-Novo Pharmaceutical Research Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Beijing Sun-Novo Pharmaceutical Research Co.?

Companies in our directory listed in the same country and business area as Beijing Sun-Novo Pharmaceutical Research Co.: China Health Group, New Journey Health Technology Group Co., Ltd.Class A, Zhejiang NHU Co., Zhejiang Starry Pharmaceutical Co., Chengdu Kanghong Pharmaceutical Group Co., Sinocelltech Group.

Investor discussion: Beijing Sun-Novo Pharmaceutical Research Co.

Members talk about Beijing Sun-Novo Pharmaceutical Research Co. (688621). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:688621 on TradingView.

Listing details

Beijing Sun-Novo Pharmaceutical Research Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688621, recorded under China. The directory classifies it as Mixed biopharma / other operations. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Beijing Sun-Novo Pharmaceutical Research Co. Ltd.
Ticker
688621
Listing
SSE
Country or territory
China
Business scope
Mixed biopharma / other operations
ISIN
CNE100005139
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.